Nautilus Biotechnology (NAUT) Other Working Capital Changes (2020 - 2026)

Nautilus Biotechnology has disclosed Other Working Capital Changes across 7 years of filings, most recently posting -$1.1 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$1.1 million, down 0.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $716000.0 (up 133.9% YoY), and the FY2025 annual result was -$544000.0, up 18.32% from the prior year.
• Other Working Capital Changes came in at -$1.1 million for Q1 2026 at Nautilus Biotechnology, down from $4.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.2 million in Q4 2025 to a low of -$4.1 million in Q4 2023.
• The 5-year median for Other Working Capital Changes is -$554000.0 (2022), against an average of -$297117.6.
• Across the five-year window, Other Working Capital Changes slumped 3848.62% in 2023 and jumped 706.94% in 2025, its largest moves.
• Nautilus Biotechnology's Other Working Capital Changes stood at $109000.0 in 2022, then plunged by 3848.62% to -$4.1 million in 2023, then jumped by 83.06% to -$692000.0 in 2024, then surged by 706.94% to $4.2 million in 2025, then tumbled by 127.29% to -$1.1 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.1 million (Q1 2026), $4.2 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.